实用肿瘤学杂志 ›› 2017, Vol. 31 ›› Issue (5): 441-443.doi: 10.11904/j.issn.1002-3070.2017.05.010

• 个案 • 上一篇    下一篇

阿帕替尼多重癌1例附文献回顾

陈丹, 李加桩, 隋红   

  1. 天津市儿童医院(天津 300134)
  • 收稿日期:2017-02-16 出版日期:2017-10-28 发布日期:2017-10-24
  • 通讯作者: 隋红,E-mail:doctorsui2003@126.com
  • 作者简介:陈丹,女,(1987-),硕士,住院医师,从事消化道肿瘤分子诊断与治疗的研究

Treatment of multiple cancer with apatinib:A case report

CHEN Dan, LI Jiazhuang, SUI Hong   

  1. Tianjin Children's Hospital,Tianjin 300134,China
  • Received:2017-02-16 Online:2017-10-28 Published:2017-10-24

摘要: 多原发癌(Multiple primary carcinomas,MPC)又称多重癌,是指同一患者的单个或多个器官组织发生2个以上的原发癌。其中同时发现或在6个月内相继发现的多重癌为同时癌,超过6个月再发现的多重癌为异时癌。多重癌发病率低,其发病率很大程度上受放化疗的影响。多重癌在临床上容易与转移瘤相混淆,两者的治疗原则及预后有很大差异。因此及时诊治有利于提高患者生存期。现将我科收治的1例多重癌病例进行报道。

关键词: 多重癌, 卵巢癌肉瘤, 阿帕替尼

Abstract: Multiple primary carcinomas(MPC),also known as multiple cancer,refers to single or multiple organ tissues occur more than two primary cancer in the same patient.In this case,it has been found multiple simultaneous cancers within 6 months.It is called metachronous cancer,which multiple cancers come from different original cancers more than 6 months.It is reported that there is a low incidence rate of multiple primary carcinomas,which is largely influenced by radiotherapy and chemotherapy.Multiple primary cancers are easy to be confused with metastatic tumors in clinical practice,both of them are quite different in terms of treatment and prognosis.Therefore,it is helpful to improve the survival of patients by timely diagnosis and treatment.This article reported a case of multiple primary carcinomas.

Key words: Multiple primary carcinomas, Ovarian carcinosroma, Apatinib

中图分类号: